Hidden risk of gadolinium-based contrast agents during interventional pain medicine procedures: a retrospective chart review.
Alejandro Hallo-CarrascoJason EldrigeDavid Anthony ProvenzanoAlexei Gonzalez-EstradaTesneem Abdel-LatifJohana KlasovaLaura Furtado-Pessoa-de-MendoncaDan YanChristine L HuntPublished in: Regional anesthesia and pain medicine (2023)
Almost all patients in our cohort had an allergy label on their chart that guided the provider to switch to gadolinium-based contrast media, but most were incomplete, ill-defined, or related to allergy to iodine but not iodinated contrast media. Such practice is not recommended based on current guidelines. The current study raises concern regarding the use of gadolinium-based contrast media in axial spine procedures, with the risk of potential severe adverse events, without evidence-based need for avoiding iodinated contrast media.
Keyphrases
- contrast enhanced
- magnetic resonance
- primary care
- end stage renal disease
- magnetic resonance imaging
- ejection fraction
- newly diagnosed
- chronic kidney disease
- computed tomography
- healthcare
- chronic pain
- prognostic factors
- peritoneal dialysis
- pain management
- spinal cord
- clinical practice
- climate change
- risk assessment
- patient reported